The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 12, 2024

Filed:

Oct. 04, 2019
Applicant:

The Rockefeller University, New York, NY (US);

Inventors:

Jakob Metzger, New York, NY (US);

Fred Etoc, New York, NY (US);

Ali Brivanlou, New York, NY (US);

Eric Siggia, New York, NY (US);

Assignee:

THE ROCKEFELLER UNIVERSITY, New York, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G06T 7/62 (2017.01); C12N 5/0735 (2010.01); G01N 1/30 (2006.01); G01N 33/50 (2006.01); G06F 18/21 (2023.01); G06F 18/214 (2023.01); G06N 3/084 (2023.01); G06T 7/00 (2017.01); G06V 10/764 (2022.01); G06V 10/82 (2022.01); G06V 20/69 (2022.01); G16B 40/00 (2019.01);
U.S. Cl.
CPC ...
G06T 7/0012 (2013.01); C12N 5/0606 (2013.01); G01N 1/30 (2013.01); G01N 33/5014 (2013.01); G01N 33/5076 (2013.01); G06F 18/214 (2023.01); G06F 18/217 (2023.01); G06N 3/084 (2013.01); G06V 10/764 (2022.01); G06V 10/82 (2022.01); G06V 20/698 (2022.01); G16B 40/00 (2019.02); C12N 2503/02 (2013.01); C12N 2510/00 (2013.01); G06T 2200/04 (2013.01); G06T 2207/20076 (2013.01); G06T 2207/20081 (2013.01); G06T 2207/20084 (2013.01); G06T 2207/30024 (2013.01); G06T 2207/30072 (2013.01); G06V 2201/03 (2022.01);
Abstract

Systems and methods for identifying molecules that are biologically active against a disease, where the method can comprise culturing a first mammalian cell population under organoid formation conditions in the presence of a test molecule to obtain a first organoid, wherein the first mammalian cell population, when cultured under the organoid formation conditions in the absence of the test molecule, results in an organoid with a disease phenotype; imaging the first organoid following exposure to the test molecule; analyzing one or more images of the first organoid using a neural network that has been trained to assign a probability score of disease or non-disease ranging between 0% and 100%; assigning the first organoid a probability score ranging between 0% and 100%; wherein the test molecule is biologically active against the disease if the probability score of the first organoid is greater than a cutoff probability score of non-disease or lower than a cutoff probability score of disease.


Find Patent Forward Citations

Loading…